These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10870501)

  • 21. Needle exchanges do not boost drug use, study says. IDU remains major HIV risk factor.
    AIDS Alert; 2003 Sep; 18(9):112, 114. PubMed ID: 14686305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of HIV risk-behavior and the identification of predictors for sharing injecting materials among young drug users in Prague, Czech Republic.
    Mikl J; Brůcková M; Jedlicka J; Malý M; Vyslouzilová S; Douda I; Minarík J; Smith P; DeHovitz J
    Cent Eur J Public Health; 2001 Nov; 9(4):228-35. PubMed ID: 11787253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.
    Platt L; Bobrova N; Rhodes T; Uusküla A; Parry JV; Rüütel K; Talu A; Abel K; Rajaleid K; Judd A
    AIDS; 2006 Oct; 20(16):2120-3. PubMed ID: 17053361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing the risk of HIV infection associated with illicit drug use.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2006 Feb; 117(2):566-71. PubMed ID: 16452382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
    Muga R; Sanvisens A; Egea JM; Tor J; Rey-Joly C
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S404-9. PubMed ID: 14648455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Needle-sharing among young IV drug users and their social network members: The influence of the injection partner's characteristics on HIV risk behavior.
    Unger JB; Kipke MD; De Rosa CJ; Hyde J; Ritt-Olson A; Montgomery S
    Addict Behav; 2006 Sep; 31(9):1607-18. PubMed ID: 16459023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study finds legalizing needles reduces HIV risk.
    AIDS Policy Law; 1995 Sep; 10(17):1, 11. PubMed ID: 11362806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(13):329-32. PubMed ID: 19357632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [AIDS epidemiology and intravenous drug use in Europe].
    Duneton P
    Sante; 1996; 6(2):74. PubMed ID: 8705129
    [No Abstract]   [Full Text] [Related]  

  • 30. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
    Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
    J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DHSS approves state's first syringe exchange programs.
    Jacobs FM
    N J Nurse; 2007; 37(5):12. PubMed ID: 18019366
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS prevention.
    Addiction; 1993 Jan; 88(1):146. PubMed ID: 8448506
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T; Fouchard JR; Ege PP
    Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sexual risk behavior in HIV-infected injection drug users.
    Battegay M; Bucher HC; Vernazza P
    Clin Infect Dis; 2004 Apr; 38(8):1175-7. PubMed ID: 15095225
    [No Abstract]   [Full Text] [Related]  

  • 35. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT).
    Booth RE; Strathdee SA
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S1-3. PubMed ID: 17889451
    [No Abstract]   [Full Text] [Related]  

  • 36. Syringe exchange.
    Jacobs R; Toynton P
    N J Med; 2003 Sep; 100(9 Suppl):55-9; quiz 79-80. PubMed ID: 14556605
    [No Abstract]   [Full Text] [Related]  

  • 37. The challenge of implementation of preventive programs in a developing country: experiences, situations, and perspectives in Uruguay.
    Osimani ML
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S422-6. PubMed ID: 14648458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The difference between men and women drug users in seroconversion risk factors].
    Strathdee SA; Galai N; Safaiean M; Celentano DD; Vlahov D; Johnson L; Nelson KE
    Sidahora; 2001 Aug; ():25-6. PubMed ID: 11681272
    [No Abstract]   [Full Text] [Related]  

  • 40. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.